HIGHLIGHTS
- who: Jordan Spurling from the (UNIVERSITY) have published the research: Letter to the authors: Costa, in the Journal: (JOURNAL)
SUMMARY
In Reply: Costa et al Jordan Spurling1*, Nicole Glowacki2 and Marc McDowell1 Spurling et_al Critical Care Dosing efficacy, which is reliant of clotting factors, is directly related to active DOAC remaining at the time of the bleed which correlates with the timing of the DOAC prior to the bleed. The statistics in this trial utilize propensity matching to match patients in coagulation factor Xa recombinant, inactivated-zhzo arm from the ANNEXA-4 trial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.